
Shaily Engineering Plastics secured a Rs 423 crore contract over four years to supply pen injectors to a large domestic pharmaceutical company, boosting investor interest despite recent stock declines. The company reported a 48.3% rise in net profit to Rs 37.38 crore and a 26.8% increase in revenue for Q3 FY26. While UBS named it a top midcap pick for 2026, technical analysis indicates ongoing selling pressure and potential further downside in the stock price.
Select a news story to see related coverage from other media outlets.